Aug 5, 2026
A UConn Health obesity specialist works through eight common GLP-1 myths
Dr. Jason Schneider says most misconceptions about GLP-1 medications trace back to an outdated view of obesity itself, and he walks through what the research does and does not say.
Jul 8, 2026
A Dietitian's Guide to Protein Snacks for GLP-1 Users
On GLP-1 medications, appetite drops sharply, and dietitians say protein-dense snacks are one practical way to keep protein intake up while meals feel harder to finish.
Jul 3, 2026
GLP321 is live.Happy 4th of July.
Happy 4th of July.
Jun 25, 2026
Medicare's GLP-1 Bridge program covers Foundayo and Zepbound at $50 a month
Eli Lilly says eligible Medicare Part D patients can get the Foundayo pill or Zepbound injection for weight management at $50 a month, starting July 1, 2026.
Jun 11, 2026
Semaglutide slowed biological aging markers in an early UC San Diego trial
Researchers report the first randomized, placebo-controlled evidence that the GLP-1 drug semaglutide slowed several markers of biological aging over 32 weeks.